Drugs / Songyou
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00805896 | Dec 2008 → Dec 2010 | hepatocellular carcinoma | Fudan University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Songyou | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00805896 ↗ |
| Known as | Songyou Granule | “Songyou Granule is a mixture of 6 herbs.” NCT00805896 ↗ |
| Action | Inhibit | “Songyou Granule can inhibit HCC cells grow” NCT00805896 ↗ |
| Route | Oral | “Effectiveness and Safety Study of TACE Plus Oral Songyou Granule for Unresectable HCC” NCT00805896 ↗ |